CERE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 5.10%

Insider Buying (Last 12 Months): $144,999,976.60

Insider Selling (Last 12 Months): $11,332,000.35

Cerevel Therapeutics Insider Trading History Chart

Cerevel Therapeutics Share Price & Price History

^$44.96

+0.30 (1.20%)

As of 08/1/2024 01:00 AM ET

Our #1 Ticker for the Rare "Retirement Window"

From Behind the Markets | Ad

We've only seen this happen three times in the past 20 years... And every time - like clockwork - it's minted an entire new class of millionaires.

Click here for our #1 "Retirement Window" Stock >>>

Cerevel Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/1/2024	Anthony Coles	Director	Sell	25,000	$41.18	$1,029,500.00	25,928
5/10/2024	Anthony Coles	Director	Sell	50,000	$42.10	$2,105,000.00	15,638
3/4/2024	Anthony Coles	Director	Sell	50,000	$41.01	$2,050,500.00	15,638
2/29/2024	Anthony Coles	Director	Sell	50,000	$41.16	$2,058,000.00	15,638
2/7/2024	John Renger	Insider	Sell	2,161	$41.54	$89,767.94	6,370
2/7/2024	Anthony Coles	Director	Sell	2,506	$41.54	$104,099.24	15,638
12/26/2023	Ramiro Sanchez	Insider	Sell	10,000	$42.47	$424,700.00	14,673
12/22/2023	Kenneth DiPietro	Insider	Sell	8,000	$41.45	$331,600.00	24,663
12/20/2023	Mark Bodenrader	Insider	Sell	7,889	$41.42	$326,762.38	17,724
12/20/2023	Susan Altschuller	CFO	Sell	13,808	$41.42	$571,927.36	16,913
12/7/2023	Scott Akamine	Insider	Sell	10,000	$41.37	$413,700.00	513
12/5/2023	Scott Akamine	Insider	Sell	7,500	$35.00	$262,500.00	513
11/8/2023	Anthony Coles	Director	Sell	100	$25.16	$2,516.00	2,704
11/3/2023	Anthony Coles	Director	Sell	61,401	$25.43	$1,561,427.43	2,704
10/16/2023	Bain Capital Investors Llc	Major Shareholder	Buy	5,480,052	$22.81	$124,999,986.12	65,679,781
10/16/2023	Perceptive Advisors Llc	Director	Buy	876,808	$22.81	$19,999,990.48	10,794,876
9/7/2023	Anthony Coles	Director	Sell	50,000	$24.07	$1,203,500.00	2,704
8/4/2023	Paul D. Burgess	Insider	Buy	21,880	$22.93	$501,708.40	21,880
8/3/2023	Ronald C. Renaud, Jr.	CEO	Buy	83,857	$23.96	$2,009,213.72	83,857
7/11/2023	Anthony Coles	Director	Sell	50,000	$30.03	$1,501,500.00	2,704
6/15/2023	Marijn E Dekkers	Director	Sell	200,000	$34.43	$6,886,000.00	402,326
6/2/2023	Mark Bodenrader	Insider	Sell	1,895	$32.95	$62,440.25	5,522
6/1/2023	Anthony Coles	CEO	Sell	50,000	$32.60	$1,630,000.00	2,704
5/4/2023	Anthony Coles	CEO	Sell	50,000	$31.47	$1,573,500.00	2,704
4/11/2023	Anthony Coles	CEO	Sell	50,000	$25.06	$1,253,000.00	2,704
3/3/2023	Anthony Coles	CEO	Sell	3,000	$27.19	$81,570.00	2,704
2/7/2023	Anthony Coles	CEO	Sell	50,000	$33.13	$1,656,500.00	2,704
1/5/2023	Anthony Coles	CEO	Sell	50,000	$29.94	$1,497,000.00	2,704
12/9/2022	Anthony Coles	CEO	Sell	50,000	$26.67	$1,333,500.00	2,704
10/4/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
9/12/2022	Deval L. Patrick	Director	Sell	47,705	$30.78	$1,468,359.90
9/8/2022	Abraham Ceesay	President	Sell	19,210	$32.50	$624,325.00
8/22/2022	Abraham Ceesay	President	Sell	9,605	$32.50	$312,162.50
8/16/2022	Perceptive Advisors Llc	Director	Buy	1,425,000	$35.00	$49,875,000.00	6,511,727
8/10/2022	John Renger	Insider	Sell	55,000	$40.50	$2,227,500.00	2,704
7/20/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
7/5/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
4/13/2022	John Renger	Insider	Sell	45,000	$34.65	$1,559,250.00	1,980
3/29/2022	John Renger	Insider	Sell	10,000	$35.00	$350,000.00
3/18/2022	John Renger	Insider	Sell	20,000	$32.50	$650,000.00
3/16/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
2/9/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
12/27/2021	John Renger	Insider	Sell	4,127	$35.00	$144,445.00
12/23/2021	John Renger	Insider	Sell	5,873	$35.00	$205,555.00
12/21/2021	John Renger	Insider	Sell	7,300	$32.50	$237,250.00
12/17/2021	John Renger	Insider	Sell	7,122	$32.50	$231,465.00
12/15/2021	John Renger	Insider	Sell	25,000	$30.02	$750,500.00
11/10/2021	John Renger	Insider	Sell	55,000	$39.86	$2,192,300.00

The $15 "Insider Secret" That Could Save Your Retirement

From Behind the Markets | Ad

What if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's right. You can grab shares of this potential retirement-maker for less than you'd pay for lunch.

Click here to discover the name and ticker of this "$15 billionaire-backed retirement stock" >>>

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

87.73% of Cerevel Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Cerevel Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/20/2024	Healthcare of Ontario Pension Plan Trust Fund	466,823	$19.09M	0.1%	-43.7%	0.256%
9/16/2024	Cubist Systematic Strategies LLC	72,546	$2.97M	0.0%	+178.2%	0.040%
8/16/2024	Water Island Capital LLC	766,933	$31.36M	3.3%	-2.8%	0.421%
8/16/2024	Algert Global LLC	39,742	$1.63M	0.1%	+22.5%	0.022%
8/16/2024	Murchinson Ltd.	100,000	$4.09M	0.6%	N/A	0.055%
8/15/2024	The Manufacturers Life Insurance Company	7,450	$0.31M	0.0%	-76.8%	0.004%
8/15/2024	Dark Forest Capital Management LP	7,846	$0.32M	0.1%	-72.9%	0.004%
8/15/2024	Armistice Capital LLC	201,743	$8.25M	0.1%	N/A	0.111%
8/14/2024	Cubist Systematic Strategies LLC	72,546	$2.97M	0.0%	+178.2%	0.040%
8/14/2024	Glazer Capital LLC	40,000	$1.64M	0.1%	N/A	0.022%
8/14/2024	Murchinson Ltd.	62,500	$2.56M	0.5%	N/A	0.034%
8/14/2024	Point72 DIFC Ltd	8,089	$0.33M	0.0%	N/A	0.004%
8/14/2024	Marshall Wace LLP	1,869,340	$76.44M	0.1%	+52.9%	1.026%
8/14/2024	Farallon Capital Management LLC	1,190,000	$48.66M	0.2%	+11.9%	0.653%
8/14/2024	Davidson Kempner Capital Management LP	260,399	$10.65M	0.2%	N/A	0.143%
8/14/2024	Xponance Inc.	8,638	$0.35M	0.0%	N/A	0.005%
8/14/2024	Magnetar Financial LLC	1,014,239	$41.47M	0.9%	-0.4%	0.557%
8/14/2024	Avoro Capital Advisors LLC	7,539,547	$308.29M	4.1%	-0.2%	4.138%
8/14/2024	Gabelli Funds LLC	347,624	$14.21M	0.1%	-46.0%	0.191%
8/14/2024	ProShare Advisors LLC	15,422	$0.63M	0.0%	-19.4%	0.008%
8/14/2024	Profund Advisors LLC	32,547	$1.33M	0.0%	-7.6%	0.018%
8/13/2024	Sei Investments Co.	12,414	$0.51M	0.0%	-20.5%	0.007%
8/13/2024	Skandinaviska Enskilda Banken AB publ	30,000	$1.23M	0.0%	-63.1%	0.016%
8/13/2024	Canada Pension Plan Investment Board	113,500	$4.64M	0.0%	-16.0%	0.062%
8/13/2024	Public Employees Retirement Association of Colorado	8,389	$0.34M	0.0%	-6.8%	0.005%
8/12/2024	Gardner Lewis Asset Management L P	192,150	$7.86M	2.2%	+57.3%	0.105%
8/12/2024	Hsbc Holdings PLC	529,071	$21.75M	0.0%	+29.7%	0.290%
8/12/2024	Amalgamated Bank	4,770	$0.20M	0.0%	+100.0%	0.003%
8/12/2024	E Fund Management Co. Ltd.	11,132	$0.46M	0.0%	+6.0%	0.006%
8/10/2024	Virtu Financial LLC	25,140	$1.03M	0.1%	N/A	0.014%
8/9/2024	Renaissance Technologies LLC	361,400	$14.78M	0.0%	-19.6%	0.198%
8/9/2024	Dimensional Fund Advisors LP	11,682	$0.48M	0.0%	-2.2%	0.006%
8/9/2024	Alpine Associates Management Inc.	2,353,694	$96.24M	4.6%	+0.5%	1.292%
8/8/2024	State of New Jersey Common Pension Fund D	45,897	$1.88M	0.0%	-32.4%	0.025%
8/7/2024	Headlands Technologies LLC	12,630	$0.52M	0.1%	+1,967.1%	0.007%
8/7/2024	Longfellow Investment Management Co. LLC	1,723	$70K	0.0%	+28.9%	0.001%
8/6/2024	Trium Capital LLP	317,731	$12.99M	1.6%	N/A	0.174%
8/6/2024	Great Lakes Advisors LLC	172,337	$7.05M	0.1%	-48.3%	0.095%
8/5/2024	New York Life Investment Management LLC	178,765	$7.31M	0.1%	+22.6%	0.098%
8/5/2024	Arizona State Retirement System	20,332	$0.83M	0.0%	+2.0%	0.011%
8/1/2024	Rhumbline Advisers	87,810	$3.59M	0.0%	-14.9%	0.048%
8/1/2024	Versor Investments LP	44,194	$1.81M	0.3%	-65.9%	0.024%
8/1/2024	CIBC Asset Management Inc	5,092	$0.21M	0.0%	N/A	0.003%
7/30/2024	Maryland State Retirement & Pension System	5,372	$0.22M	0.0%	N/A	0.003%
7/29/2024	Principal Financial Group Inc.	12,146	$0.50M	0.0%	-55.4%	0.007%
7/26/2024	GAM Holding AG	5,000	$0.20M	0.0%	-16.7%	0.003%
7/26/2024	Bank of New York Mellon Corp	249,362	$10.20M	0.0%	-13.9%	0.137%
7/12/2024	SG Americas Securities LLC	29,424	$1.20M	0.0%	+508.8%	0.016%
7/5/2024	Thurston Springer Miller Herd & Titak Inc.	3,107	$0.13M	0.0%	N/A	0.002%
5/17/2024	Comerica Bank	743	$31K	0.0%	-98.9%	0.000%
5/16/2024	California State Teachers Retirement System	122,437	$5.18M	0.0%	+63.9%	0.067%
5/16/2024	Black Maple Capital Management LP	15,702	$0.66M	0.4%	N/A	0.009%
5/16/2024	Blackstone Inc.	35,196	$1.49M	0.0%	+142.0%	0.019%
5/15/2024	Public Employees Retirement Association of Colorado	9,005	$0.38M	0.0%	-17.8%	0.005%
5/15/2024	Price T Rowe Associates Inc. MD	335,357	$14.18M	0.0%	-53.5%	0.185%
5/15/2024	GABELLI & Co INVESTMENT ADVISERS INC.	447,695	$18.92M	3.3%	+62.5%	0.247%
5/15/2024	Gabelli Funds LLC	643,859	$27.22M	0.2%	+38.3%	0.355%
5/15/2024	Gamco Investors INC. ET AL	68,837	$2.91M	0.0%	+10.5%	0.038%
5/15/2024	Affinity Asset Advisors LLC	300,000	$12.68M	1.6%	-60.0%	0.165%
5/14/2024	Capital International Investors	253,495	$10.72M	0.0%	-70.7%	0.140%
5/14/2024	Natixis	71,789	$3.04M	0.0%	-40.5%	0.040%
5/14/2024	Healthcare of Ontario Pension Plan Trust Fund	828,776	$35.03M	0.1%	+151.1%	0.456%
5/14/2024	American International Group Inc.	35,294	$1.49M	0.0%	+1.6%	0.019%
5/14/2024	Lake Street Advisors Group LLC	83,857	$3.55M	0.2%	-65.7%	0.046%
5/10/2024	Vanguard Group Inc.	7,463,911	$315.50M	0.0%	+1.2%	4.111%
5/9/2024	Chicago Capital Management LLC	39,437	$1.67M	1.8%	+192.1%	0.022%
5/9/2024	State Board of Administration of Florida Retirement System	14,070	$0.60M	0.0%	-22.5%	0.008%
5/8/2024	Entropy Technologies LP	16,131	$0.68M	0.1%	N/A	0.009%
5/8/2024	Headlands Technologies LLC	611	$26K	0.0%	N/A	0.000%
5/7/2024	Sei Investments Co.	15,607	$0.66M	0.0%	N/A	0.009%
5/7/2024	Swiss National Bank	143,200	$6.05M	0.0%	+2.5%	0.079%
5/7/2024	SG Americas Securities LLC	4,833	$0.20M	0.0%	-80.3%	0.003%
5/7/2024	Deuterium Capital Management LLC	12,572	$0.53M	1.0%	N/A	0.007%
5/2/2024	Tokio Marine Asset Management Co. Ltd.	387,800	$16.39M	0.8%	N/A	0.214%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	31,526	$1.33M	0.0%	-13.3%	0.017%
3/29/2024	Kapitalo Investimentos Ltda	180,000	$7.63M	1.6%	N/A	0.099%
3/22/2024	PNC Financial Services Group Inc.	6,500	$0.28M	0.0%	-31.6%	0.004%
3/11/2024	Vanguard Group Inc.	7,374,970	$312.70M	0.0%	+15.8%	4.062%
3/5/2024	Wellington Management Group LLP	35,578	$1.51M	0.0%	-25.5%	0.020%
3/1/2024	Goldman Sachs Group Inc.	532,757	$22.59M	0.0%	+64.2%	0.294%
2/26/2024	Centaurus Financial Inc.	2,800	$0.12M	0.0%	N/A	0.002%
2/26/2024	Virtu Financial LLC	5,803	$0.25M	0.0%	N/A	0.003%
2/26/2024	Perceptive Advisors LLC	10,965,193	$464.92M	10.4%	+8.7%	6.044%
2/15/2024	Governors Lane LP	364,400	$15.45M	1.6%	N/A	0.202%
2/14/2024	Twin Securities Inc.	232,705	$9.87M	10.4%	N/A	0.129%
2/14/2024	Avidity Partners Management LP	276,888	$11.74M	0.4%	-56.9%	0.154%
2/14/2024	PenderFund Capital Management Ltd.	9,400	$0.40M	0.0%	N/A	0.005%
2/14/2024	Avoro Capital Advisors LLC	7,555,555	$320.36M	4.4%	+690.7%	4.191%
2/14/2024	Water Island Capital LLC	588,100	$24.94M	2.6%	N/A	0.326%
2/13/2024	Bain Capital Investors LLC	65,679,781	$2.78B	60.4%	+9.1%	36.432%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	275,500	$11.68M	2.2%	N/A	0.153%
2/13/2024	Gabelli Funds LLC	465,621	$19.74M	0.2%	N/A	0.258%
2/13/2024	Capital International Investors	863,786	$36.63M	0.0%	N/A	0.479%
2/13/2024	Lake Street Advisors Group LLC	244,309	$10.36M	0.7%	+191.3%	0.136%
2/13/2024	Affinity Asset Advisors LLC	750,000	$31.80M	5.9%	+9.5%	0.416%
2/13/2024	Carmignac Gestion	44,181	$1.87M	0.0%	N/A	0.025%
2/13/2024	Rafferty Asset Management LLC	141,477	$6M	0.0%	-28.9%	0.078%
2/12/2024	Olympiad Research LP	47,304	$2.01M	1.6%	N/A	0.026%
2/12/2024	Allianz Asset Management GmbH	144,400	$6.12M	0.0%	N/A	0.080%
2/12/2024	Hsbc Holdings PLC	408,032	$17.32M	0.0%	N/A	0.226%

Data available starting January 2016

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States. It is developing Emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures or focal epilepsy, as well as in phase 1 trial to treat panic symptoms model. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; and CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and PDE4 inhibitor for the treatment of psychiatric, neuroinflammatory, and other disorders. Cerevel Therapeutics Holdings, Inc. was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $44.96

$44.96

50 Day Range

MA: $43.67

$40.30

$44.96

52 Week Range

Now: $44.96

$19.59

$44.99

Volume

N/A

Average Volume

1,709,788 shs

Market Capitalization

$8.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4

Who are the company insiders with the largest holdings of Cerevel Therapeutics?: Cerevel Therapeutics' top insider investors include:
Bain Capital Investors Llc (Major Shareholder)
Perceptive Advisors Llc (Director)
Marijn E Dekkers (Director)
Ronald C Renaud Jr (CEO)
N Anthony Coles (Director)
Kenneth Dipietro (Insider)
Paul D Burgess (Insider)
Mark Bodenrader (Insider)
Susan Altschuller (CFO)
Ramiro Sanchez (Insider)
John Renger (Insider)
N Anthony Coles (CEO)
Scott Akamine (Insider)
Learn More about top insider investors at Cerevel Therapeutics.
Who are the major institutional investors of Cerevel Therapeutics?: Cerevel Therapeutics' top institutional shareholders include:
Avoro Capital Advisors LLC — 4.14%
Alpine Associates Management Inc. — 1.29%
Marshall Wace LLP — 1.03%
Farallon Capital Management LLC — 0.65%
Magnetar Financial LLC — 0.56%
Water Island Capital LLC — 0.42%
Learn More about top institutional investors of Cerevel Therapeutics stock.
Which major investors are selling Cerevel Therapeutics stock?: In the previous quarter, CERE stock was sold by these institutional investors:
Healthcare of Ontario Pension Plan Trust Fund
Gabelli Funds LLC
Great Lakes Advisors LLC
Renaissance Technologies LLC
Versor Investments LP
Skandinaviska Enskilda Banken AB publ
Bank of New York Mellon Corp
The Manufacturers Life Insurance Company
During the last year, company insiders that have sold Cerevel Therapeutics company stock include:
Bain Capital Investors Llc (Major Shareholder)
Perceptive Advisors Llc (Director)
Marijn E Dekkers (Director)
Ronald C Renaud Jr (CEO)
N Anthony Coles (Director)
Kenneth Dipietro (Insider)
Paul D Burgess (Insider)
Learn More investors selling Cerevel Therapeutics stock.
Which major investors are buying Cerevel Therapeutics stock?: In the previous quarter, CERE stock was purchased by institutional investors including:
Millennium Management LLC
Marshall Wace LLP
Pentwater Capital Management LP
Trium Capital LLP
Davidson Kempner Capital Management LP
Susquehanna International Group LLP
Armistice Capital LLC
Cowen AND Company LLC
In the last year, these company insiders have bought Cerevel Therapeutics stock:
Bain Capital Investors Llc (Major Shareholder)
Perceptive Advisors Llc (Director)
Marijn E Dekkers (Director)
Ronald C Renaud Jr (CEO)
Learn More investors buying Cerevel Therapeutics stock.